Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening

Brief description of study

This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.

Detailed description of study

This study seeks to find out whether an oral medication called Fenofibrate can slow or prevent worsening of diabetic retinopathy.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Diabetes, Diabetic Retinopathy
Age: Between 18 Years - 99 Years
Gender: All

Ages 18+ Diagnosed with Diabetic Retinopathy

Updated on 09 Mar 2024. Study ID: 845026

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).